TransMedics Group, Inc. (TMDX) Institutional Ownership & Insider Trading

374 institutions reported holding TransMedics Group, Inc. shares in 13F filings for the quarter ended 2026-06-30, according to EquiReason's reading of their SEC filings. 14 insider trades on Form 4 since 2025-10-01.

Source: SEC EDGAR filings · figures as of 2026-06-30 · read by EquiReason

TMDXTransMedics Group, Inc.Follow TMDX — free

Medical Devices · Healthcare

—

Price chart with a free account

Market cap: 2.5B
P/E TTM: —
Dividend yield: 0.0%
52-week: —
Next earnings: 4 Nov, in 11 days

Institutions · all 13F filers

quarter to 30 Jun 2026 · filers in both quarters

374 institutions held —% of the shares. Across filers that reported both quarters, shares held changed -4.8%.

Largest moves, shares (millions)

Institutional flow by quarter

net shares added or trimmed, millions · filers in both quarters

Quarter	Holders	Shares held, M	Change	Increased	New	Decreased	Closed
Jun 26	374	35	-4.8%	125	52	115	93
Mar 26	413	36	-1.4%	134	48	112	60
Dec 25	423	37	-3.3%	144	56	112	37
Sep 25	382	38	+1.3%	132	60	104	38
Jun 25	362	37	-5.8%	107	94	108	28
Mar 25	295	39	+2.2%	111	45	83	55
Dec 24	304	38	+2.3%	120	50	77	113
Sep 24	363	36	-2.9%	124	66	109	37

TransMedics Group, Inc. — questions

Who owns TransMedics Group, Inc. stock?: 374 institutions reported TransMedics Group, Inc. shares in 13F filings for the quarter ended 2026-06-30. The largest: BlackRock, Inc. (16.1%), FMR LLC (14.8%), VANGUARD PORTFOLIO MANAGEMENT LLC (5.6%).
Are TransMedics Group, Inc. insiders buying or selling?: 14 insider trades on Form 4 since 2025-10-01; the full list, with dates, people and plan status, is on this page.

Every figure on this page comes from TransMedics Group, Inc.'s own SEC filings — see them on SEC EDGAR. Price data is licensed and shown only inside the product.

How these figures are read: methodology · EquiReason.

Important information. Figures on this page are taken from filings submitted to the U.S. Securities and Exchange Commission (SEC) and processed automatically by EquiReason. They may contain errors, omissions or delays, and EquiReason makes no representation or warranty as to their accuracy, completeness or timeliness. Always verify figures against the original filing on SEC EDGAR before relying on them.

This page is provided for general information and educational purposes only. It does not constitute investment, financial, legal or tax advice, and it is not a recommendation or an offer to buy, sell or hold any security. It does not take into account your objectives, financial situation or needs. Past performance does not guarantee future results; any reliance on this information is at your own risk. See our Disclaimer and Risk Disclosure.